ID   SKOV-3/BCRP
AC   CVCL_ZZ42
DR   cancercelllines; CVCL_ZZ42
DR   Wikidata; Q102114919
RX   PubMed=15695404;
CC   Population: Caucasian.
CC   Characteristics: Transfected with a Myc-tagged ABCG2/BCRP.
CC   Sequence variation: Mutation; HGNC; 583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Transfected with: HGNC; 74; ABCG2.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 05-10-23; Version: 7
//
RX   PubMed=15695404;
RA   Imai Y., Ishikawa E., Asada S., Sugimoto Y.;
RT   "Estrogen-mediated post transcriptional down-regulation of breast
RT   cancer resistance protein/ABCG2.";
RL   Cancer Res. 65:596-604(2005).
//